Digital medical services platform Teladoc Health (NYSE: TDOC) will be reporting results this Tuesday after market close. Here’s what investors should know.
Teladoc beat analysts’ revenue expectations by 1.7% last quarter, reporting revenues of $629.4 million, down 2.6% year on year. It was a slower quarter for the company, with full-year EBITDA guidance missing analysts’ expectations significantly and EBITDA guidance for next quarter missing analysts’ expectations significantly. It reported 102.5 million users, up 11.7% year on year.
Is Teladoc a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Teladoc’s revenue to decline 3.1% year on year to $622.6 million, a further deceleration from the 1.5% decrease it recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.31 per share.
The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Teladoc has missed Wall Street’s revenue estimates five times over the last two years.
Looking at Teladoc’s peers in the consumer internet segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Alphabet delivered year-on-year revenue growth of 13.8%, beating analysts’ expectations by 2.6%, and Coursera reported revenues up 9.8%, topping estimates by 3.7%. Alphabet’s stock price was unchanged after the resultswhile Coursera was up 36.2%.
Read our full analysis of Alphabet’s results here and Coursera’s results here.
There has been positive sentiment among investors in the consumer internet segment, with share prices up 5.1% on average over the last month. Teladoc is down 5.9% during the same time and is heading into earnings with an average analyst price target of $9.16 (compared to the current share price of $8.20).
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
